Mycosis fungoides natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 12: Line 12:
==Complications==
==Complications==
*Common complications of Cutaneous T cell lymphoma include:
*Common complications of Cutaneous T cell lymphoma include:
**Mycosis Fungoides increased risk of secondary malignancies such as primary malignancy, especially Hodgkin lymphoma, chronic leukemia, and lung cancer.
**Mycosis Fungoides increased risk of secondary malignancies such as primary malignancy, especially Hodgkin lymphoma, chronic leukemia, and lung cancer.<ref name="pmid28832009">{{cite journal |vauthors=Cengiz FP, Emiroğlu N, Onsun N |title=Frequency and Risk Factors for Secondary Malignancies in Patients with Mycosis Fungoides |journal=Turk J Haematol |volume=34 |issue=4 |pages=378–379 |date=December 2017 |pmid=28832009 |pmc=5774354 |doi=10.4274/tjh.2017.0234 |url=}}</ref>
**[Complication 2]
**[Complication 2]
**[Complication 3]
**[Complication 3]

Revision as of 20:56, 30 October 2018


Mycosis fungoides Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mycosis Fungoides from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycosis fungoides natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycosis fungoides natural history, complications and prognosis

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycosis fungoides natural history, complications and prognosis

CDC on Mycosis fungoides natural history, complications and prognosis

Mycosis fungoides natural history, complications and prognosis in the news

Blogs on Mycosis fungoides natural history, complications and prognosis

Directions to Hospitals Treating Mycosis fungoides

Risk calculators and risk factors for Mycosis fungoides natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Sogand Goudarzi, MD [3]

Overview

If left untreated, cutaneous T cell lymphoma may progress to develop cutaneous patches, plaque, and tumors. Depending on the extent of the lymphoma at the time of diagnosis, the prognosis may vary.

Natural History

  • Mycosis fungoides is initially an indolent lymphoma that may later develop peripheral lymphadenopathy and can finally progress to widespread visceral involvement.[1]
  • Cutaneous T cell lymphoma is usually initially seen by dermatologists with patients presenting with skin lesions such as erythematous patches or plaque.
  • Patients often have a history of several years of eczematous or dermatitic skin lesions before the diagnosis is finally established.
  • The skin lesions then progress from the patch stage to the plaque stage to cutaneous tumors.

Complications

  • Common complications of Cutaneous T cell lymphoma include:
    • Mycosis Fungoides increased risk of secondary malignancies such as primary malignancy, especially Hodgkin lymphoma, chronic leukemia, and lung cancer.[2]
    • [Complication 2]
    • [Complication 3]

Prognosis

  • Cutaneous T cell lymphoma is usually a slow-growing (indolent) lymphoma.[3]
  • The prognosis for people with cutaneous T cell lymphoma is based on the extent of disease and how the person responds to treatment.
  • Although more advanced stages of cutaneous T cell lymphoma may not be cured, the lymphoma can still be controlled with treatment.

Favorable prognosis

  • Early stage disease
  • Lymphoma is confined to the skin

Unfavorable prognosis

  • More advanced disease
  • Lymphoma has spread to lymph nodes
  • Lymphoma has spread to other organs


Staging

The staging of cutaneous T cell lymphoma is based on skin and lymph node involvement.[3] Staging for cutaneous T cell lymphoma is provided in the following table:

Staging of cutaneous T cell lymphoma [3]
Stage Involvement
stage I
I A
  • Less than 10% of the skin is covered with patches or plaques
I B
  • 10% or more of the skin is covered with patches or plaques
stage II
II A
  • Any amount of the skin is covered in patches or plaques
  • Lymph nodes are enlarged, but do not contain cancer
II B
  • There is one or more raised tumors on the skin
  • Lymph nodes may or may not be enlarged and do not contain cancer
stage III
III
  • Almost all of the skin is reddened
  • There may or may not be patches, plaques or skin tumors
  • Lymph nodes may or may not be enlarged and do not contain cancer
stage IV
IV A
  • Cancer has spread to the lymph nodes, but not to other organs in the body
IV B
  • Cancer has spread to other organs in the body, including the blood and bone marrow
  • Lymph nodes may be enlarged and may contain cancer

References

  1. Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 20, 2016
  2. Cengiz FP, Emiroğlu N, Onsun N (December 2017). "Frequency and Risk Factors for Secondary Malignancies in Patients with Mycosis Fungoides". Turk J Haematol. 34 (4): 378–379. doi:10.4274/tjh.2017.0234. PMC 5774354. PMID 28832009.
  3. 3.0 3.1 3.2 Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016


Template:WikiDoc Sources